title: Development of an outpatient clinic to provide pertussis vaccinations to maternity patients and family members.
abstract: OBJECTIVE
  The implementation of a hospital-based outpatient pertussis prevention program targeting maternity patients and family members is described.
  
  
  CONCLUSIONS
  Faced with a rising incidence of pertussis statewide, a large Ohio hospital formed a multidisciplinary team to ensure hospital compliance with current guidelines calling for administration of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine to all maternity patients as well as previously unvaccinated family members and likely neonatal caregivers (i.e., "cocooning"). The team had regularly scheduled meetings to identify and address fiscal, logistic, and practice-related challenges throughout the implementation process. Key challenges included (1) determining the availability of insurance reimbursement for Tdap vaccination services, (2) cultivating support for the vaccination initiative among obstetrics and maternal-fetal medicine specialists, (3) coordinating development and dissemination of educational information to patients and their families at specified points of contact, and (4) establishing an efficient registration process for family members. The outpatient vaccination clinic was located adjacent to the hospital's maternity center in order to provide convenient access. Despite limited clinic hours (three hours daily on weekdays only) and ongoing reimbursement and funding challenges, the program has improved Tdap vaccination rates in the target population and is considered a successful demonstration of the cocooning concept.
  
  
  CONCLUSIONS
  Implementation of an outpatient clinic for neonatal pertussis prevention was well accepted by family members of newborns, and Tdap vaccinations were administered to 329 family members during the first 11 months of clinic operations.
authors.affiliation: Michael A. Jakubecz, B.S.Pharm., M.B.A., is Director of Pharmacy; and Mary E. Temple-Cooper, M.S., Pharm.D., BCPS, FCCP, is Clinical Specialist, Neonatology, Pediatrics, and Maternal Fetal Medicine, Hillcrest Hospital, a Cleveland Clinic Hospital, Mayfield Heights, OH. Elliot H. Philipson, M.D., M.B.A., is Professor of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Chairman, Department of Obstetrics and Gynecology, Hillcrest Hospital.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Jakubecz
authors.affiliation: Michael A. Jakubecz, B.S.Pharm., M.B.A., is Director of Pharmacy; and Mary E. Temple-Cooper, M.S., Pharm.D., BCPS, FCCP, is Clinical Specialist, Neonatology, Pediatrics, and Maternal Fetal Medicine, Hillcrest Hospital, a Cleveland Clinic Hospital, Mayfield Heights, OH. Elliot H. Philipson, M.D., M.B.A., is Professor of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Chairman, Department of Obstetrics and Gynecology, Hillcrest Hospital. mtemple@ccf.org.
authors.forename: Mary E
authors.initials: ME
authors.lastname: Temple-Cooper
authors.affiliation: Michael A. Jakubecz, B.S.Pharm., M.B.A., is Director of Pharmacy; and Mary E. Temple-Cooper, M.S., Pharm.D., BCPS, FCCP, is Clinical Specialist, Neonatology, Pediatrics, and Maternal Fetal Medicine, Hillcrest Hospital, a Cleveland Clinic Hospital, Mayfield Heights, OH. Elliot H. Philipson, M.D., M.B.A., is Professor of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Chairman, Department of Obstetrics and Gynecology, Hillcrest Hospital.
authors.forename: Elliot H
authors.initials: EH
authors.lastname: Philipson
mesh_terms: D000554:Ambulatory Care Facilities / Q000639:trends; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage*; D005260:Female; D006771:Hospitals, Maternity / Q000639:trends; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D016730:Program Development / Q000379:methods*; D014611:Vaccination / Q000379:methods*; D014917:Whooping Cough / Q000517:prevention & control
chemical_list: D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines